Finance

Beta
Lists
600521:SHA
Zhejiang Huahai Pharmaceutical Co., Ltd.
CN¥14.45
+2.56%
(+0.36) 1D
Jun 12, 3:00:02 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 600521...
Open
CN¥14.10
High
CN¥14.49
Low
CN¥14.00
Mkt. cap
21.64B
Avg. vol.
25.67M
Volume
16.02M
P/E ratio
58.02
52-wk high
CN¥27.97
52-wk low
CN¥14.00
EPS
CN¥0.25
Shares outstanding
1.25B
No. of employees
9K
Open
CN¥14.10
High
CN¥14.49
Low
CN¥14.00
Mkt. cap
21.64B
Avg. vol.
25.67M
Volume
16.02M
P/E ratio
58.02
52-wk high
CN¥27.97
52-wk low
CN¥14.00
EPS
CN¥0.25
Shares outstanding
1.25B
No. of employees
9K
News stories
From sources across the web
About Zhejiang Huahai Pharmaceutical Co., Ltd.
CEO-
Employees8.8K
Founded1989
Headquarters-
SectorPharmaceutical industry
Websitehuahaipharm.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
2.15B
1.89B
2.18B
2.34B
Cost of goods sold
876.59M
743.42M
1.13B
988.64M
Cost of revenue
876.59M
743.42M
1.13B
988.64M
Research and development expenses
284.28M
306.29M
399.64M
218.54M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
816.09M
766.84M
703.66M
810.07M
Operating expense
1.12B
1.02B
1.15B
1.04B
Total operating expenses
2.00B
1.76B
2.28B
2.03B
Operating income
151.50M
129.57M
-104.23M
308.31M
Other non operating income
-5.45M
-16.70M
14.72M
-46.77M
EBT including unusual items
167.85M
6.30M
-105.28M
444.33M
EBT excluding unusual items
101.38M
70.67M
-177.11M
447.80M
Income tax expense
58.73M
37.52M
41.32M
45.99M
Effective tax rate
34.99%
596.03%
-39.25%
10.35%
Other operating expenses
17.52M
-36.90M
51.48M
-3.20M
Net income
112.08M
-29.13M
-113.96M
404.18M
Net profit margin
5.22%
-1.54%
-5.23%
17.31%
Earnings per share
-
-
-
-
Interest and investment income
8.64M
23.14M
6.97M
249.37M
Interest expense
-59.40M
-59.24M
-58.06M
-63.11M
Net interest expenses
-50.76M
-36.10M
-51.09M
186.27M
Depreciation and amortization charges
-
-
-
-
EBITDA
387.23M
350.99M
138.33M
550.87M
Gain or loss from assets sale
14.07K
-14.07K
-943.00
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer